Publications
Economic Aspects of the Development of New Medicines
1 January 1981
A lecture, on the economics of developing new drugs, particularly in relation to whether this should be a national or private enterprise. I have chosen to…
Health Research in England: Topic for Debate
1 January 1981
This paper is derived from the proceedings of an Office of Health Economics Study Day, held at the Royal College of Obstetricians and Gynaecology on 11…
Suicide and Deliberate Self Harm
1 January 1981
Official mortality statistics show that each year in England and Wales approximately 4,000 people take their own lives. By universal assent this figure understates the true…
Effects of Prescription Charges
12 January 1980
The annual number of NHS prescriptions dispensed by chemist and appliance contractors in the United Kingdom is falling after a seven year period of expansion. As…
Mild Hypertension
1 November 1980
The risks from untreated high blood pressure at even mildly elevated levels are well documented in quantitative terms. American insurance companies have since the interwar years…
Medicines: 50 Years of Progress 1930-1980
7 January 1980
The Office of Health Economics was invited to make a contribution to the celebration of the Golden Jubilee of the ABPI. This booklet is our response.…
Leukaemia: Towards Control
6 January 1980
Cancer < 1 min read|01/06/1980 Until the end of the 1960s leukaemia killed about 400 children annually in the United Kingdom. Excluding infant deaths (that is,…
Question of Balance: the Benefits and Risks of Pharmaceutical Innovation
1 May 1980
Since this monograph was completed, two new stories concerning the safety of medicines have been featured prominently in the British press. The first has been on…
End Stage Renal Failure
1 April 1980
The United Kingdom’s performance in the treatment of End Stage Renal Failure reflects, in microcosm, many of the strengths and weaknesses of the National Health Service.…